Biomerica, Inc. (BMRA, Financial) has declared a reverse stock split, consolidating its shares on a 1-for-8 basis. This adjustment will take effect from April 21, 2025. Post-split, Biomerica’s common stock will commence trading on a split-adjusted basis on The Nasdaq Capital Market under its existing ticker, BMRA.
The stock’s CUSIP number will change to 09061H406 following the split. The reverse split is intended to streamline the number of outstanding shares, potentially enhancing the stock's marketability and maintaining its Nasdaq listing requirements.
